As of the 2nd of February, BB Biotech owns the Market Risk Adjusted Performance of 1.3, coefficient of variation of 552.89, and Standard Deviation of 1.76. BB Biotech AG technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm BB Biotech AGsemi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation to decide if BB Biotech AG is priced fairly, providing market reflects its prevailing price of 46.7 per share.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BION, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BION
BION
BB Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between BB Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BB Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BB Biotech's market price signifies the transaction level at which participants voluntarily complete trades.
BB Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BB Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BB Biotech.
0.00
11/04/2025
No Change 0.00
0.0
In 2 months and 31 days
02/02/2026
0.00
If you would invest 0.00 in BB Biotech on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding BB Biotech AG or generate 0.0% return on investment in BB Biotech over 90 days. BB Biotech is related to or competes with Idorsia, Tecan Group, Kuros Biosciences, Basilea Pharmaceutica, Evolva Holding, Santhera Pharmaceuticals, and Molecular Partners. BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG More
BB Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BB Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BB Biotech AG upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for BB Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BB Biotech's standard deviation. In reality, there are many statistical measures that can use BB Biotech historical prices to predict the future BB Biotech's volatility.
BB Biotech appears to be very steady, given 3 months investment horizon. BB Biotech AG retains Efficiency (Sharpe Ratio) of 0.13, which signifies that the company had a 0.13 % return per unit of price deviation over the last 3 months. We have found thirty technical indicators for BB Biotech, which you can use to evaluate the volatility of the entity. Please makes use of BB Biotech's Market Risk Adjusted Performance of 1.3, standard deviation of 1.76, and Coefficient Of Variation of 552.89 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BB Biotech holds a performance score of 10. The firm owns a Beta (Systematic Risk) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BB Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding BB Biotech is expected to be smaller as well. Please check BB Biotech's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether BB Biotech's current price history will revert.
Auto-correlation
0.51
Modest predictability
BB Biotech AG has modest predictability. Overlapping area represents the amount of predictability between BB Biotech time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BB Biotech AG price movement. The serial correlation of 0.51 indicates that about 51.0% of current BB Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient
0.51
Spearman Rank Test
0.57
Residual Average
0.0
Price Variance
2.33
BB Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BB Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BB Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
BB Biotech AG Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BB Biotech AG volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BB Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BB Biotech AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BB Biotech AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BB Biotech AG price pattern first instead of the macroeconomic environment surrounding BB Biotech AG. By analyzing BB Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BB Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BB Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Most technical analysis of BION help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BION from various momentum indicators to cycle indicators. When you analyze BION charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
BB Biotech February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BION stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.